Literature DB >> 14749261

Linkage of calpain 10 to type 2 diabetes: the biological rationale.

Nancy J Cox1, M Geoffrey Hayes, Cheryl A Roe, Takafumi Tsuchiya, Graeme I Bell.   

Abstract

The follow-up studies to the original report of association of variation at calpain 10 (CAPN10) with type 2 diabetes in the Mexican-American population of Starr County, Texas, encompass a broad range of science. There are association studies on genetic variation at CAPN10 in different human populations over a range of phenotypes related to type 2 diabetes, physiological studies on the biological functions of calpain proteases, and evolutionary studies on CAPN10 and the NIDDM1 region. We review here the studies published to date on CAPN10, as well as the latest findings from positional cloning studies on a number of other complex disorders. Collectively, these studies provide perspective on the challenges of moving from the linkage mapping and positional cloning studies on which we have been focused to an understanding of the biology shaping the relationship of genotype to phenotype at loci influencing susceptibility to complex disorders like type 2 diabetes.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14749261     DOI: 10.2337/diabetes.53.2007.s19

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  16 in total

Review 1.  The genetic and molecular bases of monogenic disorders affecting proteolytic systems.

Authors:  I Richard
Journal:  J Med Genet       Date:  2005-07       Impact factor: 6.318

2.  The Genetic Basis of Type 2 Diabetes.

Authors:  Swapan Kumar Das; Steven C Elbein
Journal:  Cellscience       Date:  2006-04-30

3.  A novel 111/121 diplotype in the Calpain-10 gene is associated with type 2 diabetes.

Authors:  Eun Seok Kang; Hye Joo Kim; Moonsuk Nam; Chung Mo Nam; Chul Woo Ahn; Bong Soo Cha; Hyun Chul Lee
Journal:  J Hum Genet       Date:  2006-05-24       Impact factor: 3.172

Review 4.  From genotype to human β cell phenotype and beyond.

Authors:  Piero Marchetti; Farooq Syed; Mara Suleiman; Marco Bugliani; Lorella Marselli
Journal:  Islets       Date:  2012-09-01       Impact factor: 2.694

5.  SYNGR1 is associated with schizophrenia and bipolar disorder in southern India.

Authors:  Ranjana Verma; Shobana Kubendran; Swapan Kumar Das; Sanjeev Jain; Samir K Brahmachari
Journal:  J Hum Genet       Date:  2005-10-08       Impact factor: 3.172

6.  [The genetic revolution-impact on therapy and prevention].

Authors:  P Propping; S Aretz
Journal:  Internist (Berl)       Date:  2004-06       Impact factor: 0.743

7.  Common polymorphisms of calpain-10 and the risk of Type 2 Diabetes in a Tunisian Arab population: a case-control study.

Authors:  Intissar Ezzidi; Amira Turki; Safia Messaoudi; Molka Chaieb; Maha Kacem; Ghada M Al-Khateeb; Touhami Mahjoub; Wassim Y Almawi; Nabil Mtiraoui
Journal:  BMC Med Genet       Date:  2010-05-15       Impact factor: 2.103

8.  Type 2 diabetes candidate gene CAPN10: first, but not last.

Authors:  Martin Ridderstråle; Emma Nilsson
Journal:  Curr Hypertens Rep       Date:  2008-02       Impact factor: 5.369

Review 9.  Epistasis and its implications for personal genetics.

Authors:  Jason H Moore; Scott M Williams
Journal:  Am J Hum Genet       Date:  2009-09       Impact factor: 11.025

10.  Calpain-10 expression is elevated in pancreatic islets from patients with type 2 diabetes.

Authors:  Charlotte Ling; Leif Groop; Silvia Del Guerra; Roberto Lupi
Journal:  PLoS One       Date:  2009-08-18       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.